The role of chemistry in developing understanding of adverse outcome pathways and their application in risk assessment

Toxicology Research

Volumn 2, Issue 5, 2013, Pages 299-307

  Gutsell, Steve ^a   Russell, Paul ^a  

^a UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CONCEPTUAL FRAMEWORK; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFRARED SPECTROSCOPY; MARKETING; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; SKIN SENSITIZATION; STRUCTURE ACTIVITY RELATION;

EID: 84881534253     PISSN: 2045452X     EISSN: 20454538     Source Type: Journal    
DOI: 10.1039/c3tx50024a     Document Type: Review

References (45)

1. S. Adler D. Basketter S. Creton O. Pelkonen J. Benthem V. R. Zuang K. Andersen A. Angers-Loustau A. Aptula A. Bal-Price E. Benfenati U. Bernauer J. Bessems F. Bois A. Boobis E. Brandon S. Bremer T. Broschard S. Casati S. Coecke R. Corvi M. Cronin G. Daston W. Dekant S. Felter E. Grignard U. Gundert-Remy T. Heinonen I. Kimber J. Kleinjans H. Komulainen R. Kreiling J. Kreysa S. Leite G. Loizou G. Maxwell P. Mazzatorta S. Munn S. Pfuhler P. Phrakonkham A. Piersma A. Poth P. Prieto G. Repetto V. Rogiers G. Schoeters M. Schwarz R. Serafimova H. Tahhti E. Testai J. Delft H. Loveren M. Vinken A. Worth J. M. Zaldivar Alternative (non-animal) methods for cosmetics testing: current status and future prospects Arch. Toxicol. 2011 85 5 367 485
2. B. J. Blaauboer M. D. Barratt J. B. Houston The integrated use of alternative methods in toxicological risk evaluation Altern. Lab. Anim. 1999 27 229 237
3. G. T. Ankley R. S. Bennett R. J. Erickson D. J. Hoff M. W. Hornung R. D. Johnson D. R. Mount J. W. Nichols C. L. Russom P. K. Schmieder J. A. Serrrano J. E. Tietge D. L. Villeneuve Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment Environ. Toxicol. Chem. 2010 29 3 730 741
4. OECD, Proposal for A Template, and Guidance on Developing and Assessing the Completeness of Adverse Outcome Pathways, Appendix I, Collection of Working Definitions, http://www.oecd.org/chemicalsafety/testingofchemicals/49963576.pdf
5. H. J. M. Verhaar C. J. van Leeuwen J. L. M. Hermens Classifying environmental pollutants Chemosphere 1992 25 471 491
6. C. L. Russom S. P. Bradbury S. J. Broderius D. E. Hammermeister R. A. Drummond Predicting mode of toxic action from chemical structure: acute toxicity in the fathead minnow (Pimephales promelas) Environ. Toxicol. Chem. 1997 16 948 967 (Pubitemid 27199705)
7. Adapted from Fig. 3 'Flow diagram of the pathways associated with skin sensitization' (p. 27) from OECD (2012) Series on Testing and Assessment No. 168 ENV/JM/MONO(2012)10/PART1 The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins http://search.oecd.org/ officialdocuments/display documentpdf/?cote=env/jm/mono(2012)10/ part1&doclanguage=en
8. C. MacKay, M. Davies, V. Summerfield and G. Maxwell (submitted/personal communication). From pathways to people: applying the adverse outcome pathway (AOP) for skin sensitisation to risk assessment, ALTEX
9. V. J. Kramer M. A. Etterson M. Hecker C. A. Murphy G. Roesijadi D. J. Spade J. A. Spromberg M. Wang G. T. Ankley Adverse outcome pathways and ecological risk assessment: bridging to population-level effects Environ. Toxicol. Chem. 2011 30 1 64 76
10. A. Crum Brown T. Frazer On the connection between chemical constitution and physiological action Trans.-R. Soc. of Edinburgh 1868-9 25 151 203
11. S. Bradbury Quantitative structure-activity relationships and ecological risk assessment: an overview of predictive aquatic toxicity research Toxicol. Lett. 1995 79 229 237
12. G. Patlewicz A. Aptula D. Roberts E. Uriarte A minireview of available skin sensitisation (Q)SARs/expert systems QSAR Comb. Sci. 2008 27 60 76 (Pubitemid 351204935)
13. D. Roberts A. Aptula M. Cronin E. Hulzebos G. Patlewicz Global (Q)SARs for skin sensitisation-assessment against OECD principles SAR QSAR Environ. Res. 2007 18 343 365 (Pubitemid 46789501)
14. S. Lapenna, M. Fuart-Gatnik and A. Worth, Report of QSAR Models and Software Tools for Predicting Acute and Chronic Systemic Toxicity, JRC Scientific and Technical Reports, EUR24639 EN-2010
15. A. P. Worth M. T. D. Cronin Report of the workshop on the validation of QSARs and other computational prediction models Altern. Lab. Anim. 2004 32 703 706 (Pubitemid 38843471)
16. M. T. D. Cronin T. W. Schultz Pitfalls in QSAR J. Mol. Struct. (THEOCHEM) 2003 622 1-2 39 51
17. S. J. Enoch C. M. Ellison T. W. Schultz M. T. Cronin A review of the electrophilic reaction chemistry involved in covalent protein binding relevant to toxicity Crit. Rev. Toxicol. 2011 41 783 802
18. J. W. DeVries, Chasing "Zero" in Chemical Contaminant Analysis, Food Safety Magazine, August/September, 2006
19. A. Natsch H. Gfeller R. Emter G. Ellis Use of in vitro testing to identify an unexpected skin sensitizing impurity in a commercial product: a case study Toxicol. in Vitro 2010 24 2 411 416
20. R. Kroes J. Kleiner A. Renwick The threshold of toxicological concern concept in risk assessment Toxicol. Sci. 2005 86 2 226 230 (Pubitemid 41418634)
21. D. A. Basketter J. F. McFadden F. Gerberick A. Cockshott I. Kimber Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH Contact Dermatitis 2009 60 2 65 69
22. A. J. Murk E. Rijntjes B. J. Blaauboer R. Clewell K. M. Crofton M. L. Dingemans J. D. Furlow R. Kavlock J. Köhrle R. Opitz T. Traas T. J. Visser M. Xia A. C. Gutleb Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals Toxicol. in Vitro 2013 27 4 1320 1346
23. R. Kavlock The future of toxicity testing-the NRC vision and the EPA's ToxCast program national center for computational toxicology Neurotoxicol. Teratol. 2009 31 4 237
24. V. Y. Soldatow E. L. LeCluyse L. G. Griffith I. Rusyn In vitro models for liver toxicity testing Toxicol. Res. 2013 2 1 23 39
25. U. Marx H. Walles S. Hoffmann G. Lindner R. Horland F. Sonntag U. Klotzbach D. Sakharav A. Tonevitsky R. Lauster 'Human-on-a-ship' developments: a translational cuttingedge alternative to systemic safety assessment and efficiency evaluation of substances in laboratory animals and man? Altern. Anim. Test. 2012 40 5 235 227
26. B. J. Blaauboer K. Boekelheide H. J. Clewell M. Daneshian M. M. L. Dingemans A. M. Goldberg M. Heneweer J. Jaworska N. I. Kramer M. Leist H. Seibert E. Testai R. J. Vandebriel J. D. Yager J. Zurlo The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans ALTEX 2012 29 4 411 425
27. B. J. Blaauboer Biokinetic modeling and in vitro-in vivo extrapolations J. Toxicol. Environ. Health, Part B 2010 13 242 252
28. N. I. Kramer M. Krismartina A. Rico-Rico B. J. Blaauboer J. L. M. Hermens Quantifying processes determining the free concentration of phenanthrene in basal cytotoxicity assays Chem. Res. Toxicol. 2012 25 2 436 445
29. M. Gülden S. Mörchel S. Tahan H. Seibert Impact of protein binding on the availability and cytotoxic potency of organochlorine pesticides and chlorophenols in vitro Toxicology 2002 175 1-3 201 213 (Pubitemid 34615714)
30. M. B. Heringa R. H. M. M. Schreurs F. Busser P. T. Van Der Saag B. Van Der Burg J. L. M. Hermens Toward more useful in vitro toxicity data with measured free concentrations Environ. Sci. Technol. 2004 38 23 6263 6270 (Pubitemid 39578638)
31. E. V. Hestermann J. J. Stegeman M. E. Hahn Serum alters the uptake and relative potencies of halogenated aromatic hydrocarbons in cell culture bioassays Toxicol. Sci. 2000 53 2 316 325 (Pubitemid 30100149)
32. H. Seibert S. Mörchel M. Gülden Factors influencing nominal effective concentrations of chemical compounds in vitro: medium protein concentration Toxicol. in Vitro 2002 16 3 289 297 (Pubitemid 34521703)
33. J. Riedl R. Altenburger Physicochemical substance properties as indicators for unreliable exposure in microplate-based bioassays Chemosphere 2007 67 11 2210 2220 (Pubitemid 46441398)
34. K. Schirmer A. G. J. Chan B. M. Greenberg D. G. Dixon N. C. Bols Methodology for demonstrating and measuring the photocytotoxicity of fluoranthene to fish cells in culture Toxicol. in Vitro 1997 11 1-2 107 119 (Pubitemid 27252962)
35. R. Schreiber R. Altenburger A. Paschke E. Küster How to deal with lipophilic and volatile organic substances in microtiter plate assays Environ. Toxicol. Chem. 2008 27 8 1676 1682
36. H. Lord J. Pawliszyn Evolution of solid-phase microextraction technology J. Chromatogr., A 2000 885 1-2 153 193 (Pubitemid 30392476)
37. S. Ulrich Solid-phase microextraction in biomedical analysis J. Chromatogr., A 2000 902 1 167 194
38. B. Ekwall Overview of the final MEIC results: II. The in vitro-in vivo evaluation, including the selection of a practical battery of cell tests for prediction of acute lethal blood concentrations in humans Toxicol. in Vitro 1999 13 4-5 665 673 (Pubitemid 29354194)
39. M. Reddy, R. S. Yang, M. E. Andersen and H. J. Clewell III, Physiologically based pharmacokinetic modeling: science and applications, Wiley-Interscience, 2005
40. M. Yoon J. L. Campbell M. E. Andersen H. J. Clewell Quantitative in vitro to in vivo extrapolation of cell-based toxicity assay results Crit. Rev. Toxicol. 2012 42 8 633 652
41. J. Caldwell M. Evans K. Krishnan Cutting edge PBPK models and analyses: providing the basis for future modeling efforts and bridges to emerging toxicology paradigms J. Toxicol. 2012 852384 10.1155/2012/852384
42. T. Peyret K. Krishnan QSARs for PBPK modelling of environmental contaminants SAR QSAR Environ. Res. 2011 22 1-2 129 169
43. M. Davies R. Pendlington L. Page C. Roper D. Sanders C. Bourner C. Pease C. MacKay Determining epidermal disposition kinetics for use in an integrated nonanimal approach to skin sensitisation risk assessment Toxicol. Sci. 2011 119 2 308 318
44. Y. Dancik M. A. Miller J. Jaworska G. B. Kasting Design and performance of a spreadsheet-based model for estimating bioavailability of chemicals from dermal exposure Adv. Drug Delivery Rev. 2013 65 2 221 236
45. T. Schultz, Adverse outcome pathways: a way of linking chemical structure to in vivo toxicological hazards, chapter 14 in In Silico Toxicology: Principles and Applications, ed., M. Cronin, and, J. Madden, Royal Society of Chemistry, 2010, pp. 351-376